bioRxivBioinformaticsPreprint
Twenty novel nsSNPs may affect FLT3 gene leading to Acute Myeloid Leukemia (AML) using in silico analysis
Tarig Alsheikh, Tebyan Ameer, Ahmed NjmEldin, Dalia OmeriD, Abubaker Aghbash, Hadil Suliman, Zeinab Abdalmonem, Howiada Hamad, Saif eldowla Ayoub, Mohammed A. Hassan
Abstract
Background: Mutations within the FMS-like tyrosine kinase 3 (FLT3) gene represent one of the most common genetic alteration that disturb intracellular signaling networks with a key role in leukemia pathogenesis. laboratory studies considerable obstacle to identify functional SNPs in a specific gene. Thus, the "in silico" technique is possible now to carry out research investigations without the need for extensive lab work. Methodology: data retrieved from NCBI database and different algorithm used to analyse nsSNPs which they are: SIFT, Polyphen-2, Provean, SNAP2, P-Mut, I-Mutant, Project Hope, Raptor X, PolymiRTS and Gene MANIA. Result: Our study reveals twenty novel SNPs regarded to be the most damaging SNPs that affect structure and function of FLT3 gene using different bioinformatics algorithm. Conclusion: This study revealed 20 damaging SNPs considered to be novel nsSNP in FLT3 gene that leads to AML, by using different algorithms. Additionally, 69 functional classes were predicted in 12 SNPs in the 3UTR, among them, 31 alleles disrupted a conserved miRNA site and 37 derived alleles created a new site of miRNA. This might result in the de regulation of the gene function. These results could be valuable for molecular studying, diagnosis and treatment of AML patients.
- organism: human
- assay: GWAS summary statistics
- research focus: variant effect prediction
- approach: statistical model
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Six novel nsSNPs affect RUNX1 gene may leading to Acute Myeloid Leukemia (AML) using Bioinformatics approach
Dalia Omer, Tebyan Ameer, … Mohammed Abd El Malik Hassan·bioRxiv·Jun 26, 2023
- Computational investigation unveils pathogenic LIG3 non-synonymous mutations and therapeutic targets in acute myeloid leukemia
Md. Arif Hossen, Umme Mim Sad Jahan, … M. Nazmul Hoque·PLoS ONEPeer-reviewed·Jun 10, 2025
- In Silico Genetics Revealing Novel Mutations in CEBPA Gene Associated with Acute Myeloid Leukemia
Mujahed I. Mustafa, Zainab O. Mohammed, … Mohamed Ahmed Salih Hassan·Cancer InformaticsPeer-reviewed·Jan 1, 2019
- Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
Augustin Boudry, Sasha Darmon, … Mikaël Salson·BMC BioinformaticsPeer-reviewed·Oct 28, 2022
- Structure-Guided Discovery and Characterization of Novel FLT3 Inhibitors for Acute Myeloid Leukemia Treatment
Bishal Budha, Gourab Basu Choudhury, … Arjun Acharya·PLoS ONEPeer-reviewed·Oct 13, 2025
- Discovery of natural compounds as novel FMS-like tyrosine kinase-3 (FLT3) therapeutic inhibitors for the treatment of acute myeloid leukemia: an in silico approach
Uddalak Das, Lavanya Chandramouli, … Vidya Niranjan·Aspects of Molecular MedicinePeer-reviewed·Nov 30, 2024